Cano Health Inc. (NYSE:CANO) saw a downside of -17.01% to close Monday at $0.31 after subtracting -$0.06 on the day. The 5-day average trading volume is 18,212,160 shares of the company’s common stock. It has gained $0.5479 in the past week and touched a new high 2 times within the past 5 days. An average of 14,070,450 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 8,492,546.
CANO’s 1-month performance is -77.89% or -$1.0827 on its low of $0.2980 reached on 08/21/23. The company’s shares have touched a 52-week low of $0.34 and high of $9.75, with the stock’s rally to the 52-week high happening on 02/08/23. YTD, CANO has lost -77.57% or -$1.0627 and has reached a new high 7 times. However, the current price is down -96.85% from the 52-week high price.
Insider Transactions
CANO stock investors last saw insider trading activity on Aug 11.Camerlinck Robert (Chief Operating Officer) most recently sold 30,646 shares at $0.77 per share on Aug 11. This transaction cost the insider $23,453. Chief Clinical Officer, Aguilar Richard, sold 400,000 shares at a price of $1.31 on Jun 29. Then, on Jun 28, Chief Clinical Officer Aguilar Richard sold 150,000 shares at a price of $1.22 per share. This transaction amounted to $183,300.
Valuation Metrics
CANO stock has a beta of 0.43. Moving on to other valuation ratios, the trailing price-to-sales (P/S) ratio is 0.06 while the price-to-book (PB) in the most recent quarter is 0.58.
The trailing 12-month EBITDA margin is 0.60%. The firm’s gross profit as reported stood at $3.18 billion against revenue of $2.74 billion.
Earnings Surprise
Net income and sales went down compared to those figures reported in the previous quarter. Net income grew 96.21% to -$140.75 million, while revenue of -$28.15 million was 80.0% off the previous quarter. EBITDA for the quarter stood at more than -$216.94 million. CANO stock balance sheet for the recent quarter shows that total liabilities totaled 1.47 billion, with total debt at $1.23 billion. Shareholders hold equity totaling $538.68 million.
Let’s look briefly at Cano Health Inc. (CANO) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 21 August was 16.23% to suggest the stock is trending oversold, with historical volatility in this time period at 621.61%.
The stock’s 5-day moving average is $0.3946, reflecting a -30.71% or -$0.1362 change from its current price. CANO is currently trading -77.57% above its 20-day SMA, -72.56% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 by -76.89% and SMA200 by-90.77%.
Stochastic %K and %D was 2.54% and 4.41% and the average true range (ATR) pointed at 0.1644. The RSI (14) points at 22.14%, while the 14-day stochastic is at 0.64% with the period’s ATR at 0.1586. The stock’s 9-day MACD Oscillator is pointing at -0.2889 and -0.6328 on the 14-day charts.
Analyst Ratings
In the most recent analyst report for Cano Health Inc. (NYSE: CANO), Jefferies downgraded it to a Hold rating. They previously had a Buy rating on the stock. Analysts offering their rating for CANO stock have a consensus rating for the stock as Hold. Currently, 1 brokerage advisors rate CANO as a “sell,”, while 6 advise that investors “Hold.” 1 analysts have rated the stock as underweight. 0 rates the stock as overweight while 1 have offered a “buy” rating.
What is CANO’s price target for the next 12 months?
Analysts have a consensus price target ranging from a low of $0.50 and a high of $2.00, with their median price target at $0.80. Looking at these predictions, the average price target given by analysts is for Cano Health Inc. (CANO) stock is $0.97.
